Abstract
Cancer Biotherapy and Radiopharmaceuticals
officially retracts the paper entitled, “miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis,” by Lianshu Piao, Fei Wang, Yanyan Wang, Zirong Yang, Qianwei Li, Lifeng Cui, and Qinggong Yu (Cancer Biother Radiopharm 2019;34(3):196–202. doi: 10.1089/cbr.2018.2625) due to the discovery that the paper was purchased from a paper mill by the lead author, Lianshu Piao, and that the conducted experiments were not those of the team of authors:
“I am very sorry to inform you that the paper was purchased. This paper was written and published by others. I did not do the experimental results myself, so I can't guarantee the authenticity of the experimental results. And [o]ther members of the paper did not know anything about it, including the corresponding author, Qinggong Yu.
[sic]”
The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves and does not tolerate any violations of scientific misconduct.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
